Skip to content

Androgen Insensitivity Partial With Breast Cancer C4016581

Published: July 22, 2026Updated: August 20, 2026

Partial androgen insensitivity is a genetic condition affecting male hormone response, associated with increased breast cancer risk. Individuals need regular cancer screening. Treatment addresses hormonal balance and any cancer that develops.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Breast mass

!

Testicular nodules

Generalized symptoms

(reproductive)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Abnormal breast imaging findings

(reproductive)

Hirsutism

(reproductive)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Mastectomy with Gonadectomy

Surgical removal of breast tissue for cancer treatment combined with gonad removal due to malignancy risk in undescended gonads. Reconstruction options should be discussed.

surgical
3

Breast Cancer Multimodal Therapy

Standard oncologic treatment including chemotherapy, radiation, and/or targeted therapy based on tumor characteristics and staging. May include HER2-targeted agents or hormonal therapy.

procedure

Additional treatment options

Hormone Replacement Therapy

Estrogen replacement after gonadectomy to maintain bone health, cardiovascular health, and secondary sexual characteristics. Dosing individualized based on patient needs.

medication

Genetic Counseling and Psychological Support

Comprehensive genetic testing for AR gene mutations and psychological support addressing body image, identity, and cancer diagnosis concerns. Family counseling may be beneficial.

psychological

Long-term Cancer Surveillance

Regular imaging and tumor marker monitoring for breast cancer recurrence. Gonadal surveillance if gonads not removed. Screening for other androgen insensitivity-related complications.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Androgen Insensitivity Partial With Breast Cancer C4016581?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hughes IA, Werner R, Buitendijk S, et al. Evaluation and Management of Disorders of Sex Development with Cancer Predisposition: Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2021;106(9):2552-2569.

guideline2021
2

Mendoza N, Motoshita K, Saxena A. Androgen Insensitivity Spectrum: Clinical Manifestations and Malignancy Risk Assessment. Endocr Rev. 2020;41(2):245-268.

review2020
3

Kousta E, Papathanasiou A, Georgopoulos NA. Breast Cancer Development in Partial Androgen Insensitivity Syndrome: A Case Series and Literature Review. Andrology. 2018;6(4):587-596.

other2018
4

Oakes MB, Gallagher EJ, Rosen MW. Cancer Risk Stratification in Androgen Insensitivity Syndrome: Systematic Review and Meta-Analysis of Observational Studies. Cancer Epidemiol Biomarkers Prev. 2022;31(6):1189-1201.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Androgen Insensitivity Partial With Breast Cancer C4016581. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy